Posts tagged “Quintiles”
Quintiles Names Medical and Scientific Services Director
DataSpectrum Opens Office in U.K.
Week in Review: Region's Roller Coaster Ride Continues
We're up, we're down, we're holding on for dear life - last week saw a mix of highs and lows for the Carolinas and Georgia.
Burned by the Market: BellSouth Leads Way But Has Plenty of Company
A 'Top 10' list of losers from Georgia shows $42.45B loss in market capitalization. North Carolina's 'Top 10' sheds $14B of $27.3 in value.
Week in Review: A New CEO is the Must-Have Accessory for Q3
Changes in the executive suite dominate the news. Sales and acquisitions make headlines, too. An interesting investment deal highlights a slow week of venture moves.
Quintiles Beats Estimates in 2Q
Herd on the Street: Biotech Is 'Flavor of the Month' For the VCs
Burned by IT flameouts in recent years, some major regional VC players are shifting their focus to funding biotechnology startups. At least two other funds are starting with a biotech-only premise.
Venture Profile: Thompson Clive Venture Capital Has an Eye on Triangle
Firm, which opened Raleigh office in 2001, insists on being selective, looks for second-round and later deals up to $3 million in size.
RTP Investor Relations Group Gets Charter
Aurora Puts Part of New Fund in Pittsburgh Bioinformatics Firm
Durham VCs join $12.5 million round for TissueInformatics. Aurora sees startup's technology as huge advance for tissue analysis.
Raleigh Clinical Trials Firm Lands $11 Million in New Funding
INC Research, which focuses on oncology and central nervous system drugs, looks to expand into Europe and build its data management division. Crosspoint Venture leads round.
North Carolina Can Help Lead War Against Bio-Terror, Burr Says
Rep. Richard Burr (R-NC) to tell Biotech 2002 audience that NC is in a "tremendous position" to profit from and to lead the national effort to shore up its defenses.




















